Physicians' experiences and perceptions about withholding and withdrawal life-sustaining treatment in Chiang Mai University Hospital: a cross-sectional study.


Journal

BMC palliative care
ISSN: 1472-684X
Titre abrégé: BMC Palliat Care
Pays: England
ID NLM: 101088685

Informations de publication

Date de publication:
13 Aug 2024
Historique:
received: 02 02 2024
accepted: 10 07 2024
medline: 14 8 2024
pubmed: 14 8 2024
entrez: 13 8 2024
Statut: epublish

Résumé

Withholding or withdrawing life-sustaining treatment in end-of-life patients is a challenging ethical issue faced by physicians. Understanding physicians' experiences and factors influencing their decisions can lead to improvement in end-of-life care. To investigate the experiences of Thai physicians when making decisions regarding the withholding or withdrawal of life-sustaining treatments in end-of-life situations. Additionally, the study aims to assess the consensus among physicians regarding the factors that influence these decisions and to explore the influence of families or surrogates on the decision-making process of physicians, utilizing case-based surveys. A web-based survey was conducted among physicians practicing in Chiang Mai University Hospital (June - October 2022). Among 251 physicians (response rate 38.3%), most of the respondents (60.6%) reported that they experienced withholding or withdrawal treatment in end-of-life patients. Factors that influence their decision-making include patient's preferences (100%), prognosis (93.4%), patients' quality of life (92.8%), treatment burden (89.5%), and families' request (87.5%). For a chronic disease with comatose condition, the majority of the physicians (47%) chose to continue treatments, including cardiopulmonary resuscitation (CPR). In contrast, only 2 physicians (0.8%) would do everything, in cases when families or surrogates insisted on stopping the treatment. This increased to 78.1% if the families insisted on continuing treatment. Withholding and withdrawal of life-sustaining treatments are common in Thailand. The key factors influencing their decision-making process included patient's preferences and medical conditions and families' requests. Effective communication and early engagement in advanced care planning between physicians, patients, and families empower them to align treatment choices with personal values.

Sections du résumé

BACKGROUND BACKGROUND
Withholding or withdrawing life-sustaining treatment in end-of-life patients is a challenging ethical issue faced by physicians. Understanding physicians' experiences and factors influencing their decisions can lead to improvement in end-of-life care.
OBJECTIVES OBJECTIVE
To investigate the experiences of Thai physicians when making decisions regarding the withholding or withdrawal of life-sustaining treatments in end-of-life situations. Additionally, the study aims to assess the consensus among physicians regarding the factors that influence these decisions and to explore the influence of families or surrogates on the decision-making process of physicians, utilizing case-based surveys.
METHODS METHODS
A web-based survey was conducted among physicians practicing in Chiang Mai University Hospital (June - October 2022).
RESULTS RESULTS
Among 251 physicians (response rate 38.3%), most of the respondents (60.6%) reported that they experienced withholding or withdrawal treatment in end-of-life patients. Factors that influence their decision-making include patient's preferences (100%), prognosis (93.4%), patients' quality of life (92.8%), treatment burden (89.5%), and families' request (87.5%). For a chronic disease with comatose condition, the majority of the physicians (47%) chose to continue treatments, including cardiopulmonary resuscitation (CPR). In contrast, only 2 physicians (0.8%) would do everything, in cases when families or surrogates insisted on stopping the treatment. This increased to 78.1% if the families insisted on continuing treatment.
CONCLUSION CONCLUSIONS
Withholding and withdrawal of life-sustaining treatments are common in Thailand. The key factors influencing their decision-making process included patient's preferences and medical conditions and families' requests. Effective communication and early engagement in advanced care planning between physicians, patients, and families empower them to align treatment choices with personal values.

Identifiants

pubmed: 39138443
doi: 10.1186/s12904-024-01511-6
pii: 10.1186/s12904-024-01511-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

206

Informations de copyright

© 2024. The Author(s).

Références

Hughes MT, Smith TJ. The growth of palliative care in the United States. Annu Rev Public Health. 2014;35:459–75. https://doi.org/10.1146/annurev-publhealth-032013-182406 .
doi: 10.1146/annurev-publhealth-032013-182406 pubmed: 24641562
Yamaguchi T, Kuriya M, Morita T, et al. Palliative care development in the Asia-Pacific region: an international survey from the Asia Pacific Hospice Palliative Care Network (APHN). BMJ Support Palliat Care Mar. 2017;7(1):23–31. https://doi.org/10.1136/bmjspcare-2013-000588 .
doi: 10.1136/bmjspcare-2013-000588
Rhee JY, Garralda E, Torrado C, Blanco, S, Ayala I, Namisango E, et al. Palliative care in Africa: a scoping review from 2005–16. Lancet Oncol. 2017;18(9):e522-e531. https://doi.org/10.1016/S1470-2045(17)30420-5 .
Clark D, Baur N, Clelland D, et al. Mapping levels of Palliative Care Development in 198 countries: the Situation in 2017. J Pain Symptom Manage Apr. 2020;59(4):794–e8074. https://doi.org/10.1016/j.jpainsymman.2019.11.009 .
doi: 10.1016/j.jpainsymman.2019.11.009
Kavalieratos D, Corbelli J, Zhang D, et al. Association between Palliative Care and Patient and Caregiver outcomes: a systematic review and Meta-analysis. Jama Nov. 2016;22(20):2104–14. https://doi.org/10.1001/jama.2016.16840 .
doi: 10.1001/jama.2016.16840
Higginson IJ, Evans CJ. What is the evidence that palliative care teams improve outcomes for cancer patients and their families? Cancer J Sep-Oct. 2010;16(5):423–35. https://doi.org/10.1097/PPO.0b013e3181f684e5 .
doi: 10.1097/PPO.0b013e3181f684e5
Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med Aug. 2010;19(8):733–42. https://doi.org/10.1056/NEJMoa1000678 .
doi: 10.1056/NEJMoa1000678
Curtis JR, Vincent J-L. Ethics and end-of-life care for adults in the intensive care unit. Lancet. 2010;376(9749):1347–53. https://doi.org/10.1016/S0140-6736(10)60143-2 .
doi: 10.1016/S0140-6736(10)60143-2 pubmed: 20934213
Garrido MM, Prigerson HG. The end-of-life experience: modifiable predictors of caregivers’ bereavement adjustment. Cancer Mar. 2014;15(6):918–25. https://doi.org/10.1002/cncr.28495 .
doi: 10.1002/cncr.28495
Greer JA, Applebaum AJ, Jacobsen JC, Temel JS, Jackson VA. Understanding and addressing the role of coping in Palliative Care for patients with Advanced Cancer. J Clin Oncol Mar. 2020;20(9):915–25. https://doi.org/10.1200/jco.19.00013 .
doi: 10.1200/jco.19.00013
McQuoid-Mason DJ. Should doctors provide futile medical treatment if patients or their proxies are prepared to pay for it? S Afr Med J Jan. 2017;30(2):108–9. https://doi.org/10.7196/SAMJ.2017.v107i2.12191 .
doi: 10.7196/SAMJ.2017.v107i2.12191
WMA - The World Medical Association WM. WMA declaration on end-of-life medical care. 2022. https://www.wma.net/policies-post/wma-declaration-on-end-of-life-medical-care/
Bosslet GT, Pope TM, Rubenfeld GD, et al. An official ATS/AACN/ACCP/ESICM/SCCM Policy Statement: responding to requests for potentially inappropriate treatments in Intensive Care Units. Am J Respir Crit Care Med. 2015;191(11):1318–30. https://doi.org/10.1164/rccm.201505-0924ST .
doi: 10.1164/rccm.201505-0924ST pubmed: 25978438
Keating NL, Landrum MB, Rogers SO Jr., et al. Physician factors associated with discussions about end-of-life care. Cancer Feb. 2010;15(4):998–1006. https://doi.org/10.1002/cncr.24761 .
doi: 10.1002/cncr.24761
Koh M, Hwee PC. End-of-Life Care in the Intensive Care Unit: how Asia differs from the West. JAMA Intern Med. 2015;175(3):371–2. https://doi.org/10.1001/jamainternmed.2014.7397 .
doi: 10.1001/jamainternmed.2014.7397 pubmed: 25581079
Ko D, Evans-Barns H, Blinderman C. Withholding and withdrawing life-sustaining treatment (including artificial nutrition and hydration). In: Cherny NI, Fallon MT, Kaasa S, et al. editors. Oxford Textbook of Palliative Medicine. Oxford University Press; 2021. p. 0.
Tanaka M, Kodama S, Lee I, Huxtable R, Chung Y. Forgoing life-sustaining treatment – a comparative analysis of regulations in Japan, Korea, Taiwan, and England. BMC Med Ethics. 2020;2020/10/16(1):99. https://doi.org/10.1186/s12910-020-00535-w .
doi: 10.1186/s12910-020-00535-w
Mark NM, Rayner SG, Lee NJ, Curtis JR. Global variability in withholding and withdrawal of life-sustaining treatment in the intensive care unit: a systematic review. Intensive Care Med. Sep 2015;41(9):1572–85. https://doi.org/10.1007/s00134-015-3810-5 .
Notification of the National Health Commission On the Operational Definitions of Terms Pertaining to Palliative Care for Thailand, B.E. 2563. (A.D. 2020) (NHCO Thailand) (2021).
Phua J, Joynt GM, Nishimura M, et al. Withholding and withdrawal of life-sustaining treatments in intensive care units in Asia. JAMA Intern Med. Mar 2015;175(3):363–71. https://doi.org/10.1001/jamainternmed.2014.7386 .
Worldwide palliative care alliance WHO. Global Atlas of Palliative Care. 2nd ed. 2020.
Nilmanat K. Palliative care in Thailand: development and challenges. Can Oncol Nurs J Summer. 2016;26(3):262–4.
Vincent JL. Forgoing life support in western European intensive care units: the results of an ethical questionnaire. Crit Care Med Aug. 1999;27(8):1626–33. https://doi.org/10.1097/00003246-199908000-00042 .
doi: 10.1097/00003246-199908000-00042
Chung GS, Yoon JD, Rasinski KA, Curlin FA. US Physicians’ opinions about distinctions between withdrawing and withholding life-sustaining treatment. J Relig Health Oct. 2016;55(5):1596–606. https://doi.org/10.1007/s10943-015-0171-x .
doi: 10.1007/s10943-015-0171-x
Aita K, Kai I. Physicians’ psychosocial barriers to different modes of withdrawal of life support in critical care: a qualitative study in Japan. Soc Sci Med Feb. 2010;70(4):616–22. https://doi.org/10.1016/j.socscimed.2009.10.036 .
doi: 10.1016/j.socscimed.2009.10.036
Dickenson DL. Are medical ethicists out of touch? Practitioner attitudes in the US and UK towards decisions at the end of life. J Med Ethics Aug. 2000;26(4):254–60. https://doi.org/10.1136/jme.26.4.254 .
doi: 10.1136/jme.26.4.254
Duivenbode R, Hall S, Padela AI. Assessing relationships between Muslim Physicians’ religiosity and end-of-Life Health-Care attitudes and Treatment recommendations: an exploratory National Survey. Am J Hosp Palliat Care Sep. 2019;36(9):780–8. https://doi.org/10.1177/1049909119833335 .
doi: 10.1177/1049909119833335
Wenger NS, Carmel S. Physicians’ religiosity and end-of-life care attitudes and behaviors. Mt Sinai J Med. Oct 2004;71(5):335–43.
Kim DJ, Choi MS. Life-sustaining treatment and palliative care in patients with liver cirrhosis - legal, ethical, and practical issues. Clin Mol Hepatol Jun. 2017;23(2):115–22. https://doi.org/10.3350/cmh.2017.0018 .
doi: 10.3350/cmh.2017.0018
Alminoja A, Piili RP, Hinkka H, et al. Does decision-making in end-of-life Care Differ between Graduating Medical students and experienced Physicians? In vivo. 2019;33(3):903–9. https://doi.org/10.21873/invivo.11557 .
doi: 10.21873/invivo.11557
Hinkka H, Kosunen E, Metsänoja R, Lammi UK, Kellokumpu-Lehtinen P. Factors affecting physicians’ decisions to forgo life-sustaining treatments in terminal care. J Med Ethics. 2002;28(2):109–14. https://doi.org/10.1136/jme.28.2.109 .
doi: 10.1136/jme.28.2.109
Piili RP, Lehto JT, Luukkaala T, Hinkka H, Kellokumpu-Lehtinen P-LI. Does special education in palliative medicine make a difference in end-of-life decision-making? BMC Palliat Care. 2018;2018/07/18(1):94. https://doi.org/10.1186/s12904-018-0349-6 .
doi: 10.1186/s12904-018-0349-6
Forte DN, Vincent JL, Velasco IT, Park M. Association between education in EOL care and variability in EOL practice: a survey of ICU physicians. Intensive Care Med Mar. 2012;38(3):404–12. https://doi.org/10.1007/s00134-011-2400-4 .
doi: 10.1007/s00134-011-2400-4
Bandrauk N, Downar J, Paunovic B, On Behalf of the Canadian Critical Care Society Ethics C. Withholding and withdrawing life-sustaining treatment: the Canadian Critical Care Society position paper. Can J Anesthesia/Journal Canadien d’anesthésie 2018/01/01. 2018;65(1):105–22. https://doi.org/10.1007/s12630-017-1002-1 .
doi: 10.1007/s12630-017-1002-1
Torke AM, Moloney R, Siegler M, Abalos A, Alexander GC. Physicians’ views on the importance of patient preferences in surrogate decision-making. J Am Geriatr Soc. Mar 2010;58(3):533–8. https://doi.org/10.1111/j.1532-5415.2010.02720.x .
Bakke BM, Feuz MA, McMahan RD, Barnes DE, Li B, Volow AM, et al. Surrogate decision makers need better preparation for their role: advice from experienced surrogates. J Palliat Med. 2022/06/01 2022;25(6):857–863. https://doi.org/10.1089/jpm.2021.0283 .
Patient Safety & Risk Management Department / Quality & Safety Division Hospital Authorit Guidelines on Life-Sustaining Treatment in the Terminally Ill. 2020. https://www.ha.org.hk/haho/ho/psrm/LSTEng.pdf
Yap HY, Joynt GM, Gomersall CD. Ethical attitudes of intensive care physicians in Hong Kong: questionnaire survey. Hong Kong Med J Aug. 2004;10(4):244–50.
Withholding or Withdrawing Life-Sustaining Treatment. AMA Code of Medical Ethics. May 25, 2024. https://code-medical-ethics.ama-assn.org/ethics-opinions/withholding-or-withdrawing-life-sustaining-treatment .
Luna-Meza A, Godoy-Casasbuenas N, Calvache JA, Díaz-Amado E, Gempeler Rueda FE, Morales O, et al. Decision making in the end-of-life care of patients who are terminally ill with cancer – a qualitative descriptive study with a phenomenological approach from the experience of healthcare workers. BMC Palliat Care. 2021;20(1):76. https://doi.org/10.1186/s12904-021-00768-5 .
Nicholas LH, Langa KM, Iwashyna TJ, Weir DR. Regional variation in the association between advance directives and end-of-life Medicare expenditures. JAMA Oct. 2011;5(13):1447–53. https://doi.org/10.1001/jama.2011.1410 .
doi: 10.1001/jama.2011.1410
Horn R. I don’t need my patients’ opinion to withdraw treatment: patient preferences at the end-of-life and physician attitudes towards advance directives in England and France. Med Health Care Philos Aug. 2014;17(3):425–35. https://doi.org/10.1007/s11019-014-9558-9 .
doi: 10.1007/s11019-014-9558-9
Guidet B, Vallet H, Flaatten H, et al. The trajectory of very old critically ill patients. Intensive Care Med Feb. 2024;50(2):181–94. https://doi.org/10.1007/s00134-023-07298-z .
doi: 10.1007/s00134-023-07298-z

Auteurs

Nattanit Ketchaikosol (N)

Department of Family Medicine, Faculty of Medicine, Chiang Mai University, 110 Intawaroros Rd. Si Phum, Muang, Chiang Mai, Chiang Mai, 50200, Thailand.

Kanokporn Pinyopornpanish (K)

Department of Family Medicine, Faculty of Medicine, Chiang Mai University, 110 Intawaroros Rd. Si Phum, Muang, Chiang Mai, Chiang Mai, 50200, Thailand.
Global Health and Chronic Conditions Research Group, Chiang Mai University, Chiang Mai, Thailand.

Chaisiri Angkurawaranon (C)

Department of Family Medicine, Faculty of Medicine, Chiang Mai University, 110 Intawaroros Rd. Si Phum, Muang, Chiang Mai, Chiang Mai, 50200, Thailand.
Global Health and Chronic Conditions Research Group, Chiang Mai University, Chiang Mai, Thailand.

Nisachol Dejkriengkraikul (N)

Department of Family Medicine, Faculty of Medicine, Chiang Mai University, 110 Intawaroros Rd. Si Phum, Muang, Chiang Mai, Chiang Mai, 50200, Thailand.
Global Health and Chronic Conditions Research Group, Chiang Mai University, Chiang Mai, Thailand.

Lalita Chutarattanakul (L)

Department of Family Medicine, Faculty of Medicine, Chiang Mai University, 110 Intawaroros Rd. Si Phum, Muang, Chiang Mai, Chiang Mai, 50200, Thailand. lalitachuta.fm@gmail.com.
Global Health and Chronic Conditions Research Group, Chiang Mai University, Chiang Mai, Thailand. lalitachuta.fm@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH